Dogwood Therapeutics DWTX Payments Of Stock Issuance Costs
Payments Of Stock Issuance Costs at other companies
Other financials
Where this comes from
Reported directly by Dogwood Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PaymentsOfStockIssuanceCosts.
The official record: Dogwood Therapeutics’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dogwood Therapeutics's payments of stock issuance costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dogwood Therapeutics's payments of stock issuance costs?
- Dogwood Therapeutics (DWTX) reported payments of stock issuance costs of $106.27K in Q1 2026.
- How has Dogwood Therapeutics's payments of stock issuance costs changed year-over-year?
- Dogwood Therapeutics's payments of stock issuance costs increased by 690.0% year-over-year, from $13.45K to $106.27K.
- What does payments of stock issuance costs mean?
- Includes direct costs associated with raising capital through equity offerings, such as legal, accounting, and registration fees. Monitoring these costs helps evaluate the efficiency of the company's capital-raising process. High costs relative to proceeds may indicate unfavorable market conditions or inefficient underwriting.